BASILEA
DEAD

Serial Number

88633518

Owner

Basilea Pharmaceutica AG

Attorney

Evan A. Raynes

Filing Date

Sep 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA Trademark

Serial Number: 88633518

BASILEA is a trademark filed by Basilea Pharmaceutica AG on September 27, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Basilea Pharmaceutica AG (44 trademarks)

Grenzacherstrasse 487
CH-4005 Basel , CH

Entity Type: 99

Trademark Details

Filing Date

September 27, 2019

Registration Date

Not Registered

Published for Opposition

February 11, 2020

Goods & Services

Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 8, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 8, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 6, 2022 EXRA
SOU EXTENSION 5 GRANTED
Oct 5, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 2, 2022 AITU
SOU EXTENSION 5 FILED
Sep 21, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 21, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2022 EXRA
SOU EXTENSION 4 GRANTED
Mar 9, 2022 EX4G
SOU EXTENSION 4 FILED
Mar 9, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 9, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2021 EXRA
SOU EXTENSION 3 GRANTED
Sep 23, 2021 EX3G
SOU EXTENSION 3 FILED
Sep 23, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 23, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2021 EXRA
SOU EXTENSION 2 GRANTED
Mar 16, 2021 EX2G
SOU EXTENSION 2 FILED
Mar 16, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 16, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2020 EXRA
SOU EXTENSION 1 GRANTED
Sep 21, 2020 EX1G
SOU EXTENSION 1 FILED
Sep 21, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 21, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 31, 2019 CNSA
ASSIGNED TO EXAMINER
Dec 31, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 3, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2019 NWOS
NEW APPLICATION ENTERED
Oct 1, 2019 NWAP